1186735007: Mixed neuroendocrine-non neuroendocrine neoplasm of pancreas (disorder)

SNOMED CT Concept\Clinical finding (finding)\...

\Viscus structure finding (finding)\Abdominal organ finding\...

\Finding of pancreas\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of pancreas\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.

\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.

\Digestive system finding (finding)\Mass of digestive structure\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Mass of digestive structure\Neoplasm of digestive system\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Mass of digestive structure\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Mass of digestive structure\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Finding of pancreas\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Finding of pancreas\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Disorder of digestive system (disorder)\Neoplasm of digestive system\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Disorder of digestive system (disorder)\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Disorder of digestive system (disorder)\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Digestive system finding (finding)\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.

\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Mass of retroperitoneal structure (finding)\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal organ finding\Finding of pancreas\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal organ finding\Finding of pancreas\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal organ finding\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Abdominal organ finding\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Finding of abdominopelvic segment of trunk (finding)\Finding of abdomen\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Finding of trunk structure\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.

\Mass of body structure\Neoplasm of endocrine system (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Abdominal mass\Mass of retroperitoneal structure (finding)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of body region\Mass of trunk\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of digestive structure\Mass of pancreas (finding)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of digestive structure\Neoplasm of digestive system\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of digestive structure\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Mass of body structure\Mass of digestive structure\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.

\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neuroendocrine neoplasm (disorder)\Neuroendocrine neoplasm, malignant\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of endocrine system (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Malignant neoplastic disease (disorder)\Neuroendocrine neoplasm, malignant\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Malignant neoplastic disease (disorder)\Malignant epithelial neoplasm (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Malignant neoplastic disease (disorder)\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Malignant neoplastic disease (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Malignant neoplastic disease (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of digestive system\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Neoplasm and/or hamartoma (disorder)\Neoplastic disease\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of body system\Disorder of endocrine system\Neoplasm of endocrine system (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of body system\Disorder of endocrine system\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of body system\Disorder of digestive system (disorder)\Neoplasm of digestive system\Malignant neoplasm of digestive system (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of body system\Disorder of digestive system (disorder)\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of body system\Disorder of digestive system (disorder)\Neoplasm of digestive system\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of body system\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Neoplasm of digestive organ (disorder)\Malignant neoplasm of digestive organ\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of body system\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Neoplasm of digestive organ (disorder)\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of body system\Disorder of digestive system (disorder)\Disorder of digestive organ (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Disorder of retroperitoneal compartment (disorder)\Disorder of pancreas\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Disorder of abdominopelvic segment of trunk\Disorder of abdomen (disorder)\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Malignant neoplasm of abdomen\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Malignant neoplasm of retroperitoneum (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of retroperitoneum\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Malignant neoplasm of intraabdominal organ (disorder)\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.
\Disease\Disorder of trunk (disorder)\Neoplasm of trunk\Neoplasm of abdomen (disorder)\Neoplasm of intra-abdominal organs\Neoplasm of pancreas\Malignant neoplasm of pancreas (disorder)\Neuroendocrine neoplasm of pancreas (disorder)\A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Nov 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4667510018 A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core

4667511019 A rare neuroendocrine neoplasm of pancreas characterised by morphologically recognisable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumour volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumour growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumour is the most important prognostic factor. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core

4667506016 MiNEN (mixed neuroendocrine-non neuroendocrine neoplasm) of pancreas en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

4667507013 Mixed neuroendocrine-non neuroendocrine neoplasm of pancreas (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4667508015 Mixed neuroendocrine-non neuroendocrine neoplasm of pancreas en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4667509011 Pancreatic mixed neuroendocrine-non-neuroendocrine neoplasm en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

7723521000241115 tumeur mixte neuroendocrine et non neuroendocrine du pancréas fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

7723531000241118 néoplasme mixte neuroendocrine et non neuroendocrine du pancréas fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3428881001000118 Gemischte neuroendokrine/nicht neuroendokrine Neoplasie des Pankreas de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.	Is a	néoplasme neuroendocrine malin	false	Inferred relationship	Some
A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.	Is a	Malignant neoplasm of pancreas (disorder)	false	Inferred relationship	Some
A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.	Is a	Neuroendocrine tumor of pancreas (disorder)	false	Inferred relationship	Some
A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.	Finding site	Pancreatic structure (body structure)	true	Inferred relationship	Some	1
A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.	Associated morphology	A mixed epithelial neoplasm that is composed of both neuroendocrine and non neuroendocrine components with variable proportions for each component.	true	Inferred relationship	Some	1
A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.	Is a	Malignant epithelial neoplasm (disorder)	true	Inferred relationship	Some
A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.	Is a	Neuroendocrine neoplasm of pancreas (disorder)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Mixed ductal-neuroendocrine carcinoma of pancreas	Is a	True	A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.	Inferred relationship	Some
Primary mixed acinar endocrine-ductal carcinoma of pancreas (disorder)	Is a	True	A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.	Inferred relationship	Some

Reference Sets

Component annotation with string value reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4667510018	A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.	en	Definition	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
4667511019	A rare neuroendocrine neoplasm of pancreas characterised by morphologically recognisable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumour volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumour growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumour is the most important prognostic factor.	en	Definition	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
4667506016	MiNEN (mixed neuroendocrine-non neuroendocrine neoplasm) of pancreas	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
4667507013	Mixed neuroendocrine-non neuroendocrine neoplasm of pancreas (disorder)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4667508015	Mixed neuroendocrine-non neuroendocrine neoplasm of pancreas	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4667509011	Pancreatic mixed neuroendocrine-non-neuroendocrine neoplasm	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
7723521000241115	tumeur mixte neuroendocrine et non neuroendocrine du pancréas	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
7723531000241118	néoplasme mixte neuroendocrine et non neuroendocrine du pancréas	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
3428881001000118	Gemischte neuroendokrine/nicht neuroendokrine Neoplasie des Pankreas	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module